ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Sunshine Lake Pharma Co., Ltd. clinical trials

Also known as HEC Pharma, HEC Pharm.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 86 studies whose lead sponsor is Sunshine Lake Pharma Co., Ltd. or the company grouped under it. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 5, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Sunshine Lake Pharma with Trevi Therapeutics and Bristol-Myers Squibb →

Pipeline: 8 programs

Each counted once: 8 with a study Sunshine Lake Pharma Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Sunshine Lake Pharma Co., Ltd.’s own registered studies; Sunshine Lake Pharma Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Sunshine Lake Pharma Co., Ltd.’s studies test, most open studies first — 20 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 10 more

Coming up

9 of Sunshine Lake Pharma Co., Ltd.’s studies under way reach primary completion within a year, 3 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 4D
  3. J’27
  4. F
  5. M
  6. 2A
  7. M
  8. J
  9. 1J
  10. 1A
  11. S
  12. O
  13. 1N

Add all 9 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 86 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1315%Recruiting 11 · Not yet recruiting 2
  • Under way, not recruiting11%
  • Completed6474%
  • Stopped early89%Terminated 6 · Withdrawn 2

Phase

  • Phase 170
  • Phase 218
  • Phase 37

Where

  • China81
  • Australia2
  • United States2

Over the years

  1. 14
  2. 15
  3. 16
  4. 17
  5. 18
  6. 19
  7. 20
  8. 2421
  9. 22
  10. 23
  11. 24
  12. 25
  13. 526

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sunshine Lake Pharma Co., Ltd.

  • Sunshine Lake Pharma Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    83 studies
  • Dongguan HEC Biopharmaceutical R&D Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →

Studies

Recruiting first, then most recently updated. Showing 50 of 86. Browse all 86 →